EOM 1352: Fri 7 June 2024, 11:36

Current Edition

Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Europe

Aeromics Initiates Phase 1 Clinical Trial Of CNS Edema Inhibitor AER-271 In Healthy Human Volunteers

Aeromics, Inc. ("Aeromics" or "the Company"), a privately-held, clinical-stage pharmaceutical company focused on controlling cerebral edema for people affected by dis...
Continue Reading →
Catalyst: 12th January 2026
Quotient